Published:
Shares of Tilray Brands rocketed Friday amid rising hope that cannabis is finally on the doorstep of being rescheduled as a lower-class drug, which could open doors for further legalization and banking services.
The Washington Post
reported late Thursday that President Donald Trump was pushing to reclassify marijuana as a Schedule III drug alongside some prescription drugs like Tylenol with codeine or anabolic steroids. It is currently classified as a Schedule I drug, on par with heroin and lysergic acid diethylamide, or LSD.
